Search Results - "Hendrix, Nathaniel"

Refine Results
  1. 1

    Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage by Baral, Ranju, Fleming, Jessica, Khan, Sadaf, Higgins, Deborah, Hendrix, Nathaniel, Pecenka, Clint

    Published in PloS one (20-08-2020)
    “…Background The timing of antenatal care (ANC) visits directly affect health intervention coverage and impact, especially for those interventions requiring…”
    Get full text
    Journal Article
  2. 2

    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries by Debellut, Frédéric, Hendrix, Nathaniel, Ortiz, Justin R, Lambach, Philipp, Neuzil, Kathleen M, Bhat, Niranjan, Pecenka, Clint

    Published in PloS one (22-06-2018)
    “…Immunization of pregnant women against seasonal influenza remains limited in low- and lower-middle-income countries despite being recommended by the World…”
    Get full text
    Journal Article
  3. 3

    Economic evaluations of health system strengthening activities in low-income and middle-income country settings: a methodological systematic review by Hendrix, Nathaniel, Kwete, Xiaoxiao, Bolongaita, Sarah, Megiddo, Itamar, Memirie, Solomon Tessema, Mirkuzie, Alemnesh H, Nonvignon, Justice, Verguet, Stéphane

    Published in BMJ global health (01-03-2022)
    “…ObjectiveHealth system strengthening (HSS) activities should accompany disease-targeting interventions in low/middle-income countries (LMICs). Economic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study by Carlson, Josh J., Kim, David D., Guzauskas, Gregory F., Bennette, Caroline S., Veenstra, David L., Basu, Anirban, Hendrix, Nathaniel, Hershman, Dawn L., Baker, Laurence, Ramsey, Scott D.

    Published in Cancer medicine (Malden, MA) (01-09-2018)
    “…Background The Institute of Medicine has called for approaches to help maximize the return on investments (ROI) in cancer clinical trials. Value of Research…”
    Get full text
    Journal Article
  6. 6

    Artificial intelligence in breast cancer screening: primary care provider preferences by Hendrix, Nathaniel, Hauber, Brett, Lee, Christoph I, Bansal, Aasthaa, Veenstra, David L

    “…Abstract Background Artificial intelligence (AI) is increasingly being proposed for use in medicine, including breast cancer screening (BCS). Little is known,…”
    Get full text
    Journal Article
  7. 7

    Only One Quarter of Family Physicians Are Very Satisfied with Their Electronic Health Records Platform by Hendrix, Nathaniel, Phillips, Robert L, Bazemore, Andrew W

    “…Two decades into the era of Electronic Health Records (EHRs), the promise of streamlining clinical care, reducing burden, and improving patient outcomes has…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities by Hendrix, Nathaniel, Veenstra, David L., Cheng, Mindy, Anderson, Nicholas C., Verguet, Stéphane

    Published in Value in health (01-03-2022)
    “…Clinical artificial intelligence (AI) is a novel technology, and few economic evaluations have focused on it to date. Before its wider implementation, it is…”
    Get full text
    Journal Article
  10. 10

    Equitable Prioritization of Health Interventions by Incorporating Financial Risk Protection Weights Into Economic Evaluations by Hendrix, Nathaniel, Bolongaita, Sarah, Villano, Dominick, Memirie, Solomon Tessema, Tolla, Mieraf Taddesse, Verguet, Stéphane

    Published in Value in health (01-03-2023)
    “…Financial risk protection (FRP), or the prevention of medical impoverishment, is a major objective of health systems, particularly in low- and middle-income…”
    Get full text
    Journal Article
  11. 11

    How Do Family Physicians Document Patients' Social Needs in Electronic Health Records? by Hendrix, Nathaniel, Phillips, Robert L, Bazemore, Andrew W

    “…Social needs are critical determinants of patient health, but their capture in clinical records began recently. A representative survey of family physicians…”
    Get full text
    Journal Article
  12. 12

    Abstract P2-11-19: Estimating the long-term risk of recurrence in patients receiving HER2-targeted agents in HER2+ early-stage breast cancer (ESBC) by Veenstra, David L, Hendrix, Nathaniel, Dolan, Chantal M, Fisher, Kathryn A, Lalla, Deepa, Oestreicher, Nina, Brufsky, Adam

    Published in Cancer research (Chicago, Ill.) (15-02-2022)
    “…Abstract Background: The APHINITY, KATHERINE and ExteNET pivotal trials demonstrated the benefits of HER2-targeted agents for disease-free survival in HER2+…”
    Get full text
    Journal Article
  13. 13

    Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses by Hendrix, Nathaniel, Kim, David D., Patel, Krishna S., Devine, Beth

    Published in Medical decision making (01-04-2021)
    “…Background Health state utility values (HSUVs) are among the most influential attributes of cost-effectiveness analyses (CEAs). Our objective was to evaluate…”
    Get full text
    Journal Article
  14. 14

    Clarifying the Trade-Offs of Risk-Stratified Screening for Prostate Cancer: A Cost-Effectiveness Study by Hendrix, Nathaniel, Gulati, Roman, Jiao, Boshen, Kader, A Karim, Ryan, Stephen T, Etzioni, Ruth

    Published in American journal of epidemiology (01-10-2021)
    “…Abstract Cancer risk prediction is necessary for precision early detection, which matches screening intensity to risk. However, practical steps for translating…”
    Get full text
    Journal Article
  15. 15

    Provider preferences for attributes of artificial intelligence in breast cancer screening: A discrete choice experiment by Hendrix, Nathaniel, Hauber, A. Brett, Lee, Christoph I., Bansal, Aasthaa, Veenstra, David Leroy

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e14118 Background: One of the emerging medical applications of artificial intelligence (AI) is the interpretation of mammograms for breast cancer…”
    Get full text
    Journal Article
  16. 16

    Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database by Hendrix, Nathaniel, Marcum, Zachary A., Veenstra, David L.

    Published in Pharmacoepidemiology and drug safety (01-06-2020)
    “…Purpose Studies of medication persistence in plaque psoriasis have shown inconsistent results, likely due to differing definitions of nonpersistence and of the…”
    Get full text
    Journal Article
  17. 17

    Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United States by Jiao, Boshen, Gulati, Roman, Hendrix, Nathaniel, Gore, John L., Rais-Bahrami, Soroush, Morgan, Todd M., Etzioni, Ruth

    Published in Value in health (01-08-2021)
    “…For men with intermediate prostate-specific antigen (PSA) levels (4-10 ng/mL), urine-based biomarkers and multiparametric magnetic resonance imaging (MRI) are…”
    Get full text
    Journal Article
  18. 18

    Impact of response bias in three surveys on primary care providers' experiences with electronic health records by Hendrix, Nathaniel, Maisel, Natalya, Everson, Jordan, Patel, Vaishali, Bazemore, Andrew, Rotenstein, Lisa S, Holmgren, A Jay, Krist, Alex H, Adler-Milstein, Julia, Phillips, Robert L

    “…To identify impacts of different survey methodologies assessing primary care physicians' (PCPs') experiences with electronic health records (EHRs), we compared…”
    Get full text
    Journal Article
  19. 19

    Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis by Jiang, Shangqing, Mathias, Patrick C., Hendrix, Nathaniel, Shirts, Brian H., Tarczy-Hornoch, Peter, Veenstra, David, Malone, Daniel, Devine, Beth

    Published in The pharmacogenomics journal (01-05-2022)
    “…We constructed a cost-effectiveness model to assess the clinical and economic value of a CDS alert program that provides pharmacogenomic (PGx) testing results,…”
    Get full text
    Journal Article
  20. 20

    Using Health Economics Tools to Enhance the Clinical Utility of Artificial Intelligence-Based Diagnostics: A Case Study in Breast Cancer Screening by Hendrix, Nathaniel

    Published 01-01-2020
    “…Researchers in artificial intelligence (AI) have recently produced several products for medical diagnosis that perform at the same level as human clinicians…”
    Get full text
    Dissertation